Comparing two tests for cervical cancer detection
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy and between 18 and 85 years old.
- You must not eat for at least 6 hours and no more than 12 hours before the test.
- You need to avoid sexual activity for 24 hours before the study.
- You cannot be pregnant or think you might be pregnant.
- You have not had a hysterectomy (surgery to remove the uterus).
- You are not currently on chemotherapy, radiation, or other cancer treatment.
- You do not have HIV or hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This study uses a simple blood test to see if it can help detect cervical lesions in women infected with HPV types 16 or 18. The goal is to find a less invasive way to identify who might need further checks, like a colposcopy or biopsy.
Hear when a new I) Atypical Squamous Cells of Undetermined Significance (ASC-US) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.